Press release
The Rising Prevalence Of Respiratory Diseases Fuels Artificial Lung Market: Strengthening the Growth Trajectory of the Artificial Lung Market
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Artificial Lung Market Through 2025?
In recent times, the market size of the artificial lung has seen significant expansion. The market is predicted to swell from $2.31 billion in 2024 to $2.58 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.6%. This growth over the historic period is linked to increased knowledge among healthcare experts, higher market penetration, a rise in utilisation within home care settings, an uptick in medical tourism, and enhancements in healthcare infrastructure.
What's the Projected Size of the Global Artificial Lung Market by 2029?
Expect a significant expansion in the artificial lung market in the forthcoming years, with anticipated growth to $3.91 billion by 2029, achieving an 11.0% compound annual growth rate (CAGR). Factors contributing to this growth during the forecast period include an increased incidence of respiratory illnesses, advancements in healthcare infrastructures, acceptance of less invasive methods, improved patient lifestyles, and a high incidence of chronic obstructive pulmonary diseases. Key future trends include the incorporation of wireless technologies and artificial intelligence, progress in genomics and medical technologies, as well as the creation of smaller, more transportable artificial lungs.
View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report
Top Growth Drivers in the Artificial Lung Industry: What's Accelerating the Market?
The artificial lung market is poised for expansion, largely due to the climbing incidence of respiratory disorders. A multitude of factors are liable for the surge in respiratory diseases, including escalating air pollution, alterations in climate, and shifts in lifestyle, all of which contribute significantly to the strain on public health. Artificial lungs serve a key role in managing respiratory illnesses by oxygenating and extracting carbon dioxide from the bloodstream, thereby supplementing or replacing deficient lung functions. For example, in June 2024, the Australian Institute of Health and Welfare, a health and welfare institution based in Australia, predicted that roughly 8.5 million Australians, equating to 34% of the populace, would suffer from chronic respiratory issues. Within this, it was estimated that 2.8 million individuals, or 11% of the people, had asthma while 638,000 citizens, representing 2.5% of the population, suffered from chronic obstructive pulmonary disease (COPD). Hence, the escalating incidence of respiratory diseases is fueling the expansion of the artificial lung market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp
What Are the Key Trends Driving Artificial Lung Market Growth?
Leading firms in the artificial lung market are concentrating on the creation of cutting-edge solutions, like remote supervision and management of the device, to maintain competitiveness. This system enables medical professionals to keep track of patients' essential parameters and modify ventilation settings without being physically situated by the patients' side, hence minimizing infection risks and heightening patient safety during therapy. For instance, in August 2022, notable improvements were made by Teltonika Telemedic, a U.S. electronics manufacturer, on its artificial lung ventilator known as TELTOMED. Teltonika Telemedic was granted a unique patent for secure remote data communication and control of its ventilator. This advancement bolsters the security and dependability of patient data transmission- a vital functionality for modern medical apparatus.
What Are the Main Segments in the Artificial Lung Market?
The artificial lung market covered in this report is segmented -
1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users
Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp
Which Top Companies are Driving Growth in the Artificial Lung Market?
Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark rape*r Laboratory Inc., TransMedics Group Inc., Braile Biomédica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab
Which Regions Will Dominate the Artificial Lung Market Through 2029?
North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16591
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Rising Prevalence Of Respiratory Diseases Fuels Artificial Lung Market: Strengthening the Growth Trajectory of the Artificial Lung Market here
News-ID: 4217505 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Lung
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lung Cancer Drugs Industry Market Size Be by 2025?
The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate…
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Lending And Payments Market?
The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market?
The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and…
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787
This latest report researches the industry structure,…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…
